Literature DB >> 23480468

Ariadne's ChemEffect and Pathway Studio knowledge base.

Anton Yuryev1, Ekaterina Kotelnikova, Nikolai Daraselia.   

Abstract

IMPORTANCE OF THE FIELD: Drug discovery and development is a very complex and costly process. Understanding the detailed molecular mechanisms of a disease and drug actions can make it more efficient not only for new target discovery but also for lead prioritization, drug repositioning and development of biomarkers for drug efficacy and safety. Access to formalized knowledge about functions of proteins and small molecules is crucial for rationalization of the drug development process, and scientific publications are the main source of this knowledge. Protein knowledge networks capturing protein functions, protein-protein relations and organization of proteins in complex cellular sub-systems are making their way into modern drug discovery. Chemical networks representing multiple aspects of chemical functional information integrated into a protein systems biology network is even more advanced and promising paradigm. AREAS COVERED IN THIS REVIEW: This review describes utilization of literature-derived protein and chemical functional knowledge bases in drug development. WHAT THE READER WILL GAIN: Readers will gain an understanding of how integrated protein and chemical knowledge networks can be used for understanding and building the models of cellular events, disease mechanisms, and drug actions, finding biomarkers of drug efficacy and safety, as well as interpretation of high-throughput gene expression, proteomic and metabolomic experiments. TAKE HOME MESSAGE: Integrated literature-derived protein and chemical knowledge bases can rationalize many aspects of drug development process including drug repositioning and biomarker design.

Year:  2009        PMID: 23480468     DOI: 10.1517/17460440903413488

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  23 in total

1.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

2.  Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease.

Authors:  Khalil Mallah; Jusal Quanico; Antonella Raffo-Romero; Tristan Cardon; Soulaimane Aboulouard; David Devos; Firas Kobeissy; Kazem Zibara; Michel Salzet; Isabelle Fournier
Journal:  Mol Cell Proteomics       Date:  2019-06-16       Impact factor: 5.911

3.  RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis.

Authors:  Stephanie Devaux; Dasa Cizkova; Khalil Mallah; Melodie Anne Karnoub; Zahra Laouby; Firas Kobeissy; Juraj Blasko; Serge Nataf; Laurent Pays; Céline Mériaux; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2017-06-28       Impact factor: 5.911

4.  Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair.

Authors:  Stephanie Devaux; Dasa Cizkova; Jusal Quanico; Julien Franck; Serge Nataf; Laurent Pays; Lena Hauberg-Lotte; Peter Maass; Jan H Kobarg; Firas Kobeissy; Céline Mériaux; Maxence Wisztorski; Lucia Slovinska; Juraj Blasko; Viera Cigankova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2016-06-01       Impact factor: 5.911

5.  An Integrative Analysis of The Micro-RNAs Contributing in Stemness, Metastasis and B-Raf Pathways in Malignant Melanoma and Melanoma Stem Cell.

Authors:  Parisa Sahranavardfard; Zahra Madjd; Amir Nader Emami Razavi; Ali Reza Ghanadan; Javad Firouzi; Pardis Khosravani; Saeid Ghavami; Esmaeil Ebrahimie; Marzieh Ebrahimi
Journal:  Cell J       Date:  2021-07-17       Impact factor: 2.479

6.  Splice-disrupt genomic variants in prostate cancer.

Authors:  Ibrahim O Alanazi; Salman F Alamery; Esmaeil Ebrahimie; Manijeh Mohammadi-Dehcheshmeh
Journal:  Mol Biol Rep       Date:  2022-03-14       Impact factor: 2.742

7.  Clustering gene expression regulators: new approach to disease subtyping.

Authors:  Mikhail Pyatnitskiy; Ilya Mazo; Maria Shkrob; Elena Schwartz; Ekaterina Kotelnikova
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape.

Authors:  Stacy Alyse Malaker; Jusal Quanico; Antonella Raffo-Romero; Firas Kobeissy; Soulaimane Aboulouard; Dominique Tierny; Carolyn Ruth Bertozzi; Isabelle Fournier; Michel Salzet
Journal:  Cell Chem Biol       Date:  2021-06-07       Impact factor: 8.116

9.  In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer.

Authors:  Soulaimane Aboulouard; Maxence Wisztorski; Marie Duhamel; Philippe Saudemont; Tristan Cardon; Fabrice Narducci; Anne-Sophie Lemaire; Firas Kobeissy; Eric Leblanc; Isabelle Fournier; Michel Salzet
Journal:  Cell Rep Med       Date:  2021-06-15

10.  Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.

Authors:  Susana Murteira; Zied Ghezaiel; Slim Karray; Michel Lamure
Journal:  J Mark Access Health Policy       Date:  2013-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.